Emerald Advisers, LLC
- SEC CIK
- 0001015083
- Latest filing
- Aug 5, 2026
AMLX holding history
Amylyx Pharmaceuticals, Inc. in every 13F filed by Emerald Advisers, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AMLX overviewAll 13F holders of AMLXFull Q2 2026 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −802,610−100.0% | Sold out | Holders |
| Q4 2023 | 802,610 | $11.8M | 0.5% | −35,962−4.3% | Reduced | Holders |
| Q3 2023 | 838,572 | $15.4M | 0.7% | +6,764+0.8% | Added | Holders |
| Q2 2023 | 831,808 | $17.9M | 0.8% | −141,027−14.5% | Reduced | Holders |
| Q1 2023 | 972,835 | $28.5M | 1.4% | +135,926+16.2% | Added | Holders |
| Q4 2022 | 836,909 | $30.9M | 1.5% | +235,683+39.2% | Added | Holders |
| Q3 2022 | 601,226 | $16.9M | 0.9% | +601,226 | New | Holders |